Zhouyi Sun

Zhouyi Sun

Auto-generated profile, based on publicly available information

Zhouyi Sun

Department of Surgery The Fourth Affiliated Hospital, Zhejiang University School of Medicine Yiwu China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2025 in Exploration
Verified
Journal Article
Open access
ZSZhouyi Sun
Zhouyi Sun
HZHuali Zuo
Huali Zuo
KZKai Zhang
Kai Zhang
YLYang Liu
Yang Liu
QWQianwen Wang
Qianwen Wang
ZTZhe Tang
Zhe Tang
Autophagy is a process of engulfing cytoplasmic proteins or organelles, thereby fulfilling cells’ metabolic needs and the renewal of specific organelles. Given its key roles in tumor progression, autophagy has attracted tremendous attention in cancer therapies. Notably, there is a megatrend to integrating autophagy regulation into mainstream treatments. This review focuses on autophagy‐targeting nanomedicine (ApT‐NM) to modulate autophagy in tumor therapy, including the unmodified and functionalized nanoparticles that target tumors by carrying autophagy modulators. On the one hand, it can reverse treatment resistance by inhibiting protective autophagy, and on the other hand, it can promote the death of cancer cells through type II apoptosis by inducing autophagy. Moreover, advanced nanoplatforms combining various treatments (such as chemotherapy, radiotherapy, photothermal therapy, and photodynamic therapy, etc.) have also been summarized. Last, the future perspectives and directions for ApT‐NM research are provided, hoping to emphasize this rising filed and promote the development of ApT‐NM.

10 January 2025 in Advanced Functional Materials
Verified
Journal Article
Open access
ZSZhouyi Sun
Zhouyi Sun
YLYang Liu
Yang Liu
TZTangye Zeng
Tangye Zeng
HZHuali Zuo
Huali Zuo
QHQitao Hu
Qitao Hu
WCWeiyu Chen
Weiyu Chen
The incidence of hepatocellular carcinoma (HCC) is increasing worldwide annually. However, traditional treatments like surgery, targeted therapy, and immunotherapy have limited efficacy, often accompanied by adverse reactions or drug resistance. Precision therapy via tumor‐specific gene therapy and targeted delivery would potentially improve therapeutic efficiency with desirable biosafety. In this study, CHRDL‐1 is identified in clinic specimens and comprehensively evaluated as a tumor suppressor gene against HCC via activation of the Hippo pathway. By integrating pDNA‐CHRDL‐1, layered double hydroxides, membrane‐penetrating peptide and folic acid, a novel nano‐platform (FT‐BL@P) is designed for HCC‐targeted gene therapy. As prepared FT‐BL@P effectively suppress the growth of HCC cells and induces apoptosis both in vitro and in vivo. Combined with JPH203, a phase 2 L‐type amino acid transporter 1 (LAT‐1) inhibitor, FT‐BL@P achieves synergistic anti‐tumor effects in a xenograft HCC model, suggesting that the co‐delivery of CHRDL‐1 combined with JPH203 holds promise as a potential therapeutic strategy for HCC.

26 September 2024
Verified
Preprint
Open access
ZSZhouyi Sun
Zhouyi Sun
HZHuali Zuo
Huali Zuo
KZKai Zhang
Kai Zhang
YLYang Liu
Yang Liu
QWQianwen Wang
Qianwen Wang
ZTZhe Tang
Zhe Tang
Autophagy is a process of engulfing cytoplasmic proteins or organelles, thereby fulfilling cells’ metabolic needs and the renewal of specific organelles. Given its key roles in tumor progression, autophagy has attracted tremendous attention in cancer therapies. Notably, there is a megatrend to integrating autophagy regulation into mainstream treatments. This review focuses on autophagy-targeting nanomedicine (ApT-NM) to modulate autophagy in tumor therapy, including the unmodified and functionalized nanoparticles that target tumors by carrying autophagy modulators. On the one hand, it can reverse treatment resistance by inhibiting protective autophagy, and on the other hand, it can promote the death of cancer cells through type II apoptosis by inducing autophagy. Moreover, advanced nanoplatforms combining various treatments (such as chemotherapy, radiotherapy, photothermal therapy, and photodynamic therapy, etc.) have also been summarized. Last, the future perspectives and directions for ApT-NM research are provided, hoping to emphasize this rising filed and promote the development of ApT-NM.